Johnson & Johnson Pharmaceutical Research & Development, LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Jun 30, 2011
  • Last warning letter 2009
Inspections 6 0 OAI
Recalls 0 0 Class I
Warning letters 1 Latest Aug 10, 2009
510(k) clearances 0 None on file

Johnson & Johnson Pharmaceutical Research & Development, LLC has 0 FDA recalls, 6 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Johnson & Johnson Pharmaceutical Research & Development, LLC, the most recent on Aug 10, 2009.

What these totals cover: FDA records filed under the name "Johnson & Johnson Pharmaceutical Research & Development, LLC" and its spelling variant "Johnson And Johnson Pharmaceutical Research And Development". Records filed under related names are not included; see Related names.

Latest recall
Z-0284-2027 · Sep 23, 2026 · filed under Ethicon
Latest inspection
Jun 30, 2011 · NAI

Newer recall under related name Ethicon: Sep 23, 2026, Z-0284-2027.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections6Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Johnson & Johnson Pharmaceutical Research & Development, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Johnson & Johnson Pharmaceutical Research & Development, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Johnson & Johnson Pharmaceutical Research & Development, LLC FDA Warning Letters

1 warning letter on Aug 10, 2009.

IssuedSubjectIssuing officeClose-out letter
Aug 10, 2009 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

6 inspections from Mar 24, 2009 to Jun 30, 2011.

DateSiteProductClassificationFEI
Jun 30, 2011Raritan, NJDrugsNo Action Indicated (NAI)3006192174
Apr 12, 2011Raritan, NJDrugsNo Action Indicated (NAI)3006192174
Aug 20, 2010Raritan, NJDrugsVoluntary Action Indicated (VAI)3006192174
Apr 14, 2009Raritan, NJDrugsVoluntary Action Indicated (VAI)3006192174
Mar 27, 2009Raritan, NJDrugsVoluntary Action Indicated (VAI)3006192174
Mar 24, 2009Raritan, NJDrugsNo Action Indicated (NAI)3006192174
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Johnson & Johnson Pharmaceutical Research & Development, LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Aug 10, 2009.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3006192174Raritan, NJ6Jun 30, 2011

Johnson & Johnson Pharmaceutical Research & Development, LLC and the FDA: common questions

Has Johnson & Johnson Pharmaceutical Research & Development, LLC received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Johnson & Johnson Pharmaceutical Research & Development, LLC. The most recent is dated Aug 10, 2009.

Has Johnson & Johnson Pharmaceutical Research & Development, LLC received an FDA Form 483?

FDA has not published a Form 483 for "Johnson & Johnson Pharmaceutical Research & Development, LLC" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Johnson & Johnson Pharmaceutical Research & Development, LLC?

The most recent FDA inspection on file ended Jun 30, 2011 at Raritan, NJ and was classified NAI. FDA has 6 inspections of Johnson & Johnson Pharmaceutical Research & Development, LLC on file.

Need more than this page shows? Ask about Johnson & Johnson Pharmaceutical Research & Development, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.